Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis

Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis

Francesco Manfredonia1, Livia Pasquali1, Angela Dardano2, Alfonso Iudice1, Luigi Murri1, Fabio Monzani21Department of Neuroscience and 2Department of Internal Medicine, University of Pisa, Pisa, ItalyAbstract: Interferon (INF) β 1a 22 or 44 µg (Rebif®) administ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francesco Manfredonia, Livia Pasquali, Angela Dardano, Alfonso Iudice, Luigi Murri, Fabio Monzani
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/f9ba7fc011e5483988eb9c66774311ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f9ba7fc011e5483988eb9c66774311ef

Ejemplares similares